Nomura Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.5M | Buy |
109,358
+97,566
| +827% | +$21M | 0.03% | 287 |
|
|
2026
Q1 | $2.56M | Sell |
11,792
-24,575
| -68% | -$5.45M | 0.01% | 845 |
|
|
2025
Q4 | $8.31M | Sell |
36,367
-21,342
| -37% | -$4.86M | 0.01% | 601 |
|
|
2025
Q3 | $13.4M | Buy |
57,709
+30,058
| +109% | +$6.12M | 0.02% | 426 |
|
|
2025
Q2 | $5.13M | Sell |
27,651
-11,637
| -30% | -$2.16M | 0.01% | 571 |
|
|
2025
Q1 | $8.23M | Sell |
39,288
-38,259
| -49% | -$7.44M | 0.02% | 535 |
|
|
2024
Q4 | $13.8M | Buy |
77,547
+51,784
| +201% | +$9.52M | 0.02% | 420 |
|
|
2024
Q3 | $5.09M | Sell |
25,763
-17,026
| -40% | -$3.18M | 0.01% | 648 |
|
|
2024
Q2 | $7.34M | Buy |
42,789
+16,349
| +62% | +$2.71M | 0.01% | 554 |
|
|
2024
Q1 | $4.81M | Sell |
26,440
-22,297
| -46% | -$3.84M | 0.01% | 650 |
|
|
2023
Q4 | $7.55M | Buy |
48,737
+43,763
| +880% | +$6.38M | 0.02% | 529 |
|
|
2023
Q3 | $741K | Sell |
4,974
-14,590
| -75% | -$2.14M | ﹤0.01% | 1049 |
|
|
2023
Q2 | $2.64M | Buy |
+19,564
| New | +$2.87M | 0.01% | 651 |
|
|
2023
Q1 | – | Sell |
-1,754
| Closed | -$268K | – | 1412 |
|
|
2022
Q4 | $284K | Buy |
+1,754
| New | +$269K | ﹤0.01% | 1055 |
|
|
2022
Q3 | – | Sell |
-53,481
| Closed | -$7.67M | – | 1653 |
|
|
2022
Q2 | $8.22M | Sell |
53,481
-32,517
| -38% | -$4.97M | 0.03% | 404 |
|
|
2022
Q1 | $14M | Sell |
85,998
-103,337
| -55% | -$15M | 0.04% | 271 |
|
|
2021
Q4 | $25.6M | Buy |
189,335
+13,865
| +8% | +$1.64M | 0.07% | 219 |
|
|
2021
Q3 | $19.1M | Buy |
175,470
+133,039
| +314% | +$15.2M | 0.05% | 229 |
|
|
2021
Q2 | $4.78M | Buy |
42,431
+23,201
| +121% | +$2.61M | 0.01% | 591 |
|
|
2021
Q1 | $2.08M | Sell |
19,230
-55,311
| -74% | -$5.92M | ﹤0.01% | 848 |
|
|
2020
Q4 | $7.99M | Buy |
74,541
+31,936
| +75% | +$3.07M | 0.01% | 480 |
|
|
2020
Q3 | $3.73M | Buy |
42,605
+39,413
| +1,235% | +$3.71M | 0.01% | 533 |
|
|
2020
Q2 | $313K | Buy |
+3,192
| New | +$281K | ﹤0.01% | 946 |
|
|
2019
Q4 | – | Sell |
-1,570,924
| Closed | -$130M | – | 1075 |
|
|
2019
Q3 | $115M | Buy |
1,570,924
+1,525,380
| +3,349% | +$105M | 0.43% | 40 |
|
|
2019
Q2 | $3.34M | Buy |
45,544
+13,321
| +41% | +$1.05M | 0.01% | 578 |
|
|
2019
Q1 | $2.6M | Sell |
32,223
-27,210
| -46% | -$2.23M | 0.01% | 599 |
|
|
2018
Q4 | $5.47M | Buy |
59,433
+35,077
| +144% | +$3.08M | 0.02% | 474 |
|
|
2018
Q3 | $2.31M | Sell |
24,356
-54,822
| -69% | -$5.2M | 0.01% | 691 |
|
|
2018
Q2 | $7.34M | Sell |
79,178
-74,853
| -49% | -$7.31M | 0.02% | 433 |
|
|
2018
Q1 | $14.6K | Buy |
154,031
+32,753
| +27% | +$3.6M | 0.03% | 322 |
|
|
2017
Q4 | $13.7M | Buy |
121,278
+12,995
| +12% | +$1.22M | 0.02% | 378 |
|
|
2017
Q3 | $9.62M | Sell |
108,283
-59,625
| -36% | -$4.54M | 0.02% | 391 |
|
|
2017
Q2 | $12.2M | Buy |
167,908
+72,469
| +76% | +$4.87M | 0.03% | 311 |
|
|
2017
Q1 | $6.22M | Sell |
95,439
-56,438
| -37% | -$3.55M | 0.02% | 407 |
|
|
2016
Q4 | $9.51M | Buy |
151,877
+99,805
| +192% | +$6.09M | 0.02% | 383 |
|
|
2016
Q3 | $3.29M | Sell |
52,072
-9,603
| -16% | -$622K | 0.01% | 549 |
|
|
2016
Q2 | $3.81M | Sell |
61,675
-27,905
| -31% | -$1.7M | 0.01% | 486 |
|
|
2016
Q1 | $5.1M | Sell |
89,580
-33,145
| -27% | -$1.85M | 0.02% | 350 |
|
|
2015
Q4 | $7.26M | Sell |
122,725
-127,893
| -51% | -$7.37M | 0.02% | 313 |
|
|
2015
Q3 | $13.7M | Buy |
250,618
+157,093
| +168% | +$10.2M | 0.05% | 192 |
|
|
2015
Q2 | $6.21M | Buy |
93,525
+33,416
| +56% | +$2.18M | 0.02% | 385 |
|
|
2015
Q1 | $3.5M | Sell |
60,109
-345,484
| -85% | -$20.9M | 0.01% | 473 |
|
|
2014
Q4 | $26.2M | Buy |
405,593
+212,436
| +110% | +$13.4M | 0.07% | 178 |
|
|
2014
Q3 | $11.1M | Buy |
193,157
+180,012
| +1,369% | +$9.99M | 0.03% | 399 |
|
|
2014
Q2 | $739K | Sell |
13,145
-298,968
| -96% | -$15.7M | ﹤0.01% | 1586 |
|
|
2014
Q1 | $16M | Buy |
312,113
+175,092
| +128% | +$8.85M | ﹤0.01% | 335 |
|
|
2013
Q4 | $7.23M | Sell |
137,021
-143,123
| -51% | -$7.03M | 0.03% | 301 |
|
|
2013
Q3 | $12.5M | Buy |
280,144
+136,391
| +95% | +$6.05M | 0.08% | 210 |
|
|
2013
Q2 | $5.97M | Buy |
+143,753
| New | +$6.29M | 0.05% | 278 |
|
Other funds holding ABBV
Nomura Holdings's ABBV Position: Q2 2026 in Review
Nomura Holdings increased its AbbVie (ABBV) stake by 827% in Q2 2026, buying an estimated $21M and bringing the position to 109,358 shares worth $27.5M. The position accounts for 0.03% of the portfolio, ranked #287.
Nomura Holdings first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $115M in Q3 2019. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Nomura Holdings held 109,358 shares of AbbVie worth $27.5M as of Q2 2026.
- Nomura Holdings bought 97,566 AbbVie shares in Q2 2026, an estimated $21M.
- AbbVie made up 0.03% of Nomura Holdings's portfolio in Q2 2026, its #287 holding.
- Nomura Holdings first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Nomura Holdings's AbbVie position peaked at $115M in Q3 2019.
- 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.